Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Casebia Therapeutics logo — An innovative gene editing company discovering and developin...

Casebia Therapeutics

An innovative gene editing company discovering and developing curative treatments for genetic diseases

Founded 2016 United States Cambridge, United States 1 employees Biotechnology

General Information

Company Name Casebia Therapeutics
Founded Year 2016
Location United States Cambridge, United States +2
Employees 1
Industries Biotechnology
Social

Get notified when Casebia Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Casebia Therapeutics

Casebia Therapeutics is a biotechnology startup based in the United States, founded in 2016. Positioning itself as an innovative gene editing company, it is dedicated to discovering and developing curative treatments for genetic diseases. Through a strategic partnership between Bayer and CRISPR Therapeutics, Casebia aims to create breakthrough therapeutics targeting blood disorders, blindness, and congenital heart disease. This unique partnership leverages the strengths of each entity. CRISPR Therapeutics contributes its proprietary CRISPR-Cas9 gene-editing technology and intellectual property, while Bayer provides its protein engineering expertise and disease know-how. This collaboration represents a significant investment in the development of target delivery systems, focusing on bringing systemic in vivo CRISPR-Cas9 gene editing technology applications to patients. With a focus on targeting severe genetic diseases, Casebia is at the forefront of biotechnological advancement. While specific investment and investor details are not disclosed, the company's strategic partnership and innovative approach position it as a key player in the biotechnology industry, with the potential to revolutionize gene therapy and precision medicine.

Taxonomy: Gene Editing, Therapeutics, Medical Innovation, CRISPR-Cas9, Protein Engineering, Targeted Delivery, Hematology, Ophthalmology, Rare Diseases

No funding data available for Casebia Therapeutics yet.

Get notified when Casebia Therapeutics raises funding

Casebia Therapeutics Alternatives & Competitors

Casebia Therapeutics vs
CRISPR Therapeutics
CRISPR Therapeutics United States

Gene-based medicines for patients with serious diseases

IPO
350 employees
Biopharma, Biotechnology
Compare Casebia Therapeutics vs CRISPR Therapeutics
Casebia Therapeutics vs
Recombinetics
Recombinetics United States

Delivering the Next Evolution of Healthcare

Series A
17 employees
Biotechnology, Health Care
Casebia Therapeutics vs
Dharmacon
Dharmacon

Dharmacon revolutionized the field of RNA synthesis in 1995 with the introduction of 2’-ACE synthesi...

10 employees
Biotechnology
Also compare with: Casebia Therapeutics vs HuidaGene Therapeutics HuidaGene Therapeutics Casebia Therapeutics vs Mammoth Biosciences Mammoth Biosciences

FAQ About Casebia Therapeutics

An innovative gene editing company discovering and developing curative treatments for genetic diseases
Casebia Therapeutics was founded in 2016.
Casebia Therapeutics is headquartered in Cambridge, United States.
Casebia Therapeutics operates in the following industries: Biotechnology.
Casebia Therapeutics has approximately 1 employees.
Top alternatives and competitors to Casebia Therapeutics include CRISPR Therapeutics, Recombinetics, Dharmacon, Modalis Therapeutics, HuidaGene Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Casebia Therapeutics and CRISPR Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Casebia Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes